skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Evaluation of radioactive phosphorus in the palliation of metastatic bone lesions from carcinoma of the breast and prostate

Journal Article · · Radiology; (United States)
 [1];
  1. Univ. of Western Ontario, London, Canada

Radioactive phosphorus effected substantial palliation of intractable bone pain in 17 of 33 (51.5%) women with metastatic carcinoma of the breast and in 14 of 15 (93.3%) men with metastatic carcinoma of the prostate. No significant difference in the overall response rate was found between androgen and paralthormone priming prior to radiophosphorus therapy. The degree of response was not dependent on total dose of /sup 32/P within the range of 9 to 18 mCi (333 to 666 MPq). Myelosuppression was a transient complication in 9 of 33 patients with metastatic breast carcinoma and in 7 of 15 patients with metastatic prostate carcinoma. Symptomatic hypercalcemia was an infrequent complication of radiophosphorus therapy irrespective of the priming regimen.

OSTI ID:
5246462
Journal Information:
Radiology; (United States), Vol. 134:1
Country of Publication:
United States
Language:
English

Similar Records

External beam radiotherapy for palliation of pain from metastatic carcinoma of the prostate
Journal Article · Fri Jan 01 00:00:00 EST 1982 · J. Urol.; (United States) · OSTI ID:5246462

Single-dose half-body irradiation for the palliation of multiple bone metastases from solid tumors: a preliminary report
Conference · Mon Jun 01 00:00:00 EDT 1981 · Int. J. Radiat. Oncol., Biol. Phys.; (United States) · OSTI ID:5246462

Robotic Image-Guided Stereotactic Radiotherapy, for Isolated Recurrent Primary, Lymph Node or Metastatic Prostate Cancer
Journal Article · Wed Feb 01 00:00:00 EST 2012 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:5246462